Lindoso Jéssica Vanessa Dos Santos, Alencar Salmon Rocha, Santos Andressa Amorim Dos, Mello Neto Renato Sampaio, Mendes Ana Victória da Silva, Furtado Mariely Mendes, Silva Maisa Gomes da, Brito Ana Karolinne da Silva, Batista Emanuelle Karine Frota, Baêta Silvia de Araújo França, Moreira Nunes Paulo Humberto, Lucarini Massimo, Durazzo Alessandra, Arcanjo Daniel Dias Rufino, Martins Maria do Carmo de Carvalho E
Departamento de Biofísica e Fisiologia, Universidade Federal do Piauí, Campus Ministro Petrônio Portella, Teresina 64049-550, Brazil.
Departamento de Clínica e Cirurgia Veterinária, Universidade Federal do Piauí, Centro de Ciências Agrárias, Teresina 64049-550, Brazil.
Biology (Basel). 2022 Apr 7;11(4):562. doi: 10.3390/biology11040562.
This study aimed to investigate the effects of oral administration of Mart. ("bacuri") seed butter (BSB) on oxidative stress and diabetes mellitus-related parameters in streptozotocin-induced (STZ) diabetic rats. Diabetes mellitus was induced in female Wistar rats (180-250 g) by the intraperitoneal administration of STZ (45 mg/kg, b.w). BSB (25, 50, and 100 mg/kg) was administered to animals for four weeks. The effect on weight gain, food intake, blood glucose, glycated hemoglobin, hepatic transaminases, plasma and liver TBARS and MPO activity, erythrocyte SOD activity, non-protein sulfhydryl groups (SH-NP), and histopathology of the liver tissue was investigated. BSB at the dose of 100 mg/kg had a positive effect on the reduction in glycated hemoglobin percentage and increased albumin concentration, as well as decreased ALT and AST levels and increased SH-NP liver levels in treated animals compared to normal control rats. Moreover, BSB had no effects on weight gain, food intake, and fasting glucose. Thus, the BSB presented marked properties in improvement of hepatic antioxidant defenses, which demonstrates BSB as a potential hepatoprotective agent in metabolic disorders.
本研究旨在探讨口服马氏(“巴西莓”)种子黄油(BSB)对链脲佐菌素诱导(STZ)的糖尿病大鼠氧化应激及糖尿病相关参数的影响。通过腹腔注射STZ(45 mg/kg,体重)诱导雌性Wistar大鼠(180 - 250 g)患糖尿病。给动物灌胃BSB(25、50和100 mg/kg),持续四周。研究其对体重增加、食物摄入量、血糖、糖化血红蛋白、肝转氨酶、血浆和肝脏丙二醛(TBARS)及髓过氧化物酶(MPO)活性、红细胞超氧化物歧化酶(SOD)活性、非蛋白巯基(SH-NP)以及肝脏组织病理学的影响。与正常对照大鼠相比,100 mg/kg剂量的BSB对降低糖化血红蛋白百分比、提高白蛋白浓度具有积极作用,同时降低了治疗动物的谷丙转氨酶(ALT)和谷草转氨酶(AST)水平,并提高了肝脏SH-NP水平。此外,BSB对体重增加、食物摄入量和空腹血糖无影响。因此,BSB在改善肝脏抗氧化防御方面具有显著特性,表明BSB在代谢紊乱中是一种潜在的肝脏保护剂。